Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

By LabMedica International staff writers
Posted on 25 Jul 2025

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. More...

However, obtaining PRP traditionally requires expensive centrifugation techniques, may prematurely activate platelets, and often reduce their therapeutic effectiveness. These methods also involve complex equipment and handling that limit their use in low-resource or point-of-care settings. To overcome these challenges, researchers have developed a novel method that separates PRP directly from blood without requiring centrifugation. The new approach yields high-quality, minimally activated platelets, offering a cost-effective and portable alternative to existing methods.

This solution, developed at the University of the Basque Country (Leioa, Spain), is a disposable, low-cost device based on gravity sedimentation, a process where denser particles settle under gravity. Unlike traditional centrifuge-based equipment, the system is made from laser-cut acrylic sheets and special adhesives, making it affordable and easy to manufacture. This innovation is the result of over a decade of research into Lab-on-a-Chip technologies—compact systems that replicate laboratory functions on a single microdevice. During their studies, the team observed that plasma separated in these devices was rich in low-activated platelets, prompting a redesign for therapeutic purposes. The device can extract about 300 microliters of PRP from 1 milliliter of blood in 40 minutes and can be scaled for different blood volumes.

The system was tested and validated through performance metrics, including platelet activation levels and blood component separation. Compared to traditional methods, platelet activation was significantly reduced to 8.2% from 31%, while maintaining the mean platelet volume crucial for PRP efficacy. It also eliminated 98% of red blood cells and 96% of white blood cells. The findings, published in Lab on a Chip, demonstrate the device’s potential for use in personalized treatments, resource-limited clinics, and home healthcare.

Related Links:
University of the Basque Country


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.